BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3253659)

  • 21. Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy.
    Jaime-Pérez JC; Rodríguez-Romo LN; González-Llano O; Chapa-Rodríguez A; Gómez-Almaguer D
    Br J Haematol; 2009 Mar; 144(5):794-5. PubMed ID: 19036096
    [No Abstract]   [Full Text] [Related]  

  • 22. Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.
    Rivera GK; Zhou Y; Hancock ML; Gajjar A; Rubnitz J; Ribeiro RC; Sandlund JT; Hudson M; Relling M; Evans WE; Pui CH
    Cancer; 2005 Jan; 103(2):368-76. PubMed ID: 15599932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy.
    Tunç B; Oner AF; Hiçsönmez G
    Turk J Pediatr; 2002; 44(1):1-4. PubMed ID: 11858371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biology and treatment of acute lymphoblastic leukemia.
    Pieters R; Carroll WL
    Pediatr Clin North Am; 2008 Feb; 55(1):1-20, ix. PubMed ID: 18242313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Drug sensitivity of tumor cells in varieties of acute childhood leukemia].
    Shman TV; Belevtsev MV; Buglova SE
    Vopr Onkol; 2005; 51(5):558-62. PubMed ID: 16756010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient hyperglycemia during childhood acute lymphocytic leukemia chemotherapy: an old event revisited.
    Spinola-Castro AM; Siviero-Miachon AA; Andreoni S; Tosta-Hernandez PD; Macedo CR; Lee ML
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):465-72. PubMed ID: 19701154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
    Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
    Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allogeneic transplantation versus intensive chemotherapy in first-remission acute leukemia: is there a "best choice"?
    Mayer RJ
    J Clin Oncol; 1988 Oct; 6(10):1532-6. PubMed ID: 3049948
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute leukemia in children.
    Choudhry VP; Arya LS; Marwaha RK; Pati H; Saraya AK
    Indian Pediatr; 1988 Aug; 25(8):734-9. PubMed ID: 3220559
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of chosen parameters of the immune system in children with acute lymphoblastic leukemia.
    Mazur B; Olejnik I; Wylezol I; Sonta-Jakimczyk D; Szczepanski T; Karpe J
    Pediatr Hematol Oncol; 2003 Jun; 20(4):303-8. PubMed ID: 12746162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are elevated serum levels of IGFBP-2 after intensive chemotherapy of childhood acute lymphoblastic leukemia a risk factor of relapse?
    Kitszel A; Krawczuk-Rybak M
    Adv Med Sci; 2007; 52():147-53. PubMed ID: 18217408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral mucosal lesions in patients with acute leukemias and related disorders due to cytotoxic therapy.
    Baliga AM; Brave VR; Vyas HA
    J Indian Soc Pedod Prev Dent; 1995 Aug; 13(1):25-9. PubMed ID: 9522736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Individualized treatment of leukemia patients by monitoring of minimal residual disease (MRD) based on WT1 assay].
    Ogawa H; Sugiyama H
    Rinsho Ketsueki; 1998 Feb; 39(2):107-8. PubMed ID: 9545812
    [No Abstract]   [Full Text] [Related]  

  • 35. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S; Paydas S; Disel U; Sahin B
    Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Infection status and clinical significance of Epstein-Barr virus in pediatric leukemia---a report of 35 cases].
    Lu Y; Sun LR; Pang XY; Lu ZH; Sui AH
    Ai Zheng; 2007 Jan; 26(1):54-7. PubMed ID: 17222368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia during induction of acute lymphocytic leukemia.
    Wilmott RW
    J Pediatr; 2009 Jul; 155(1):A2. PubMed ID: 19559280
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current status of complete remission rate of acute leukemia in Shanghai].
    Shanghai Leukemia Cooperative Group Shanghai 200040 China
    Zhonghua Xue Ye Xue Za Zhi; 2000 Jan; 21(1):17-9. PubMed ID: 11876954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematological and biochemical changes in acute leukemic patients after chemotherapy.
    Rasheed A; Iqtidar A; Khan S
    Zhongguo Yao Li Xue Bao; 1996 May; 17(3):207-8. PubMed ID: 9812735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
    Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
    Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.